共 23 条
[1]
Averch H.(1962)Behavior of the Firm Under Regulatory Constraint American Economic Review 52 1052-1069
[2]
Johnson L.(1997)Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU International Journal of the Economics of Business 4 301-321
[3]
Danzon P. M.(1991)The Cost of Innovation in the Pharmaceutical Industry Journal of Health Economics 10 107-142
[4]
DiMasi J. A.(2003)The Price of Innovation: New Estimates of Drug Development Costs Journal of Health Economics 22 151-185
[5]
Hansen R. W.(2001)Global Pricing Strategies for Innovative Essential Drugs Int J Biotechnology 3 338-349
[6]
Grabowski H. G.(2001)Patent Protection, Transnational Corporations, and Market Structure: A Simulation Study of the Indian Pharmaceutical Industry Journal of Industry, Competition and Trade 1 101-121
[7]
Lasagna L.(1990)A New Look at the Returns and Risks to Pharmaceutical R & D Management Science 36 804-821
[8]
DiMasi J. A.(1988)Price Discrimination and Patent Policy RAND Journal of Economics 19 253-265
[9]
Hansen R. W.(1994)Parallel Imports, Demand Dispersion, and International Price Discrimination Journal of International Economics 37 167-195
[10]
Grabowski H. G.(1997)Products Liability and Prescription Drug Prices in Canada and the United States J. of Law and Economics 40 203-244